ATE310538T1 - Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden - Google Patents

Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden

Info

Publication number
ATE310538T1
ATE310538T1 AT97915728T AT97915728T ATE310538T1 AT E310538 T1 ATE310538 T1 AT E310538T1 AT 97915728 T AT97915728 T AT 97915728T AT 97915728 T AT97915728 T AT 97915728T AT E310538 T1 ATE310538 T1 AT E310538T1
Authority
AT
Austria
Prior art keywords
drug
carboxyl group
group
spacer
carrier
Prior art date
Application number
AT97915728T
Other languages
English (en)
Inventor
Shuichi Sugawara
Masahiro Kajiki
Hiroshi Kuriyama
Nobuya Kitaguchi
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE310538T1 publication Critical patent/ATE310538T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT97915728T 1996-04-15 1997-04-15 Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden ATE310538T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11525796 1996-04-15
JP32588096 1996-11-22
PCT/JP1997/001303 WO1997038727A1 (fr) 1996-04-15 1997-04-15 Composite medicamenteux

Publications (1)

Publication Number Publication Date
ATE310538T1 true ATE310538T1 (de) 2005-12-15

Family

ID=26453799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915728T ATE310538T1 (de) 1996-04-15 1997-04-15 Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden

Country Status (7)

Country Link
US (1) US6458347B1 (de)
EP (1) EP0895784B1 (de)
JP (2) JP4420472B2 (de)
AT (1) ATE310538T1 (de)
CA (1) CA2251742C (de)
DE (1) DE69734709D1 (de)
WO (1) WO1997038727A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE310538T1 (de) * 1996-04-15 2005-12-15 Asahi Chemical Ind Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden
US6380405B1 (en) 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6541508B2 (en) 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
DK1407784T3 (da) * 2001-06-25 2011-02-28 Ajinomoto Kk Antitumormidler
TWI313609B (en) * 2001-08-21 2009-08-21 Mitsubishi Tanabe Pharma Corp Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10324710A1 (de) 2003-05-30 2004-12-16 Supramol Parenteral Colloids Gmbh Stärkederivatkomplexe
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US7282590B2 (en) * 2004-02-12 2007-10-16 The Research Foundation Of State University Of New York Drug conjugates
BRPI0515573A (pt) * 2004-09-22 2008-07-29 Nippon Kayaku Kk copolìmero por blocos, preparação de micela e agente anticáncer contendo a mesma como o ingrediente ativo
US9603941B2 (en) * 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
JP5249016B2 (ja) 2006-03-28 2013-07-31 日本化薬株式会社 タキサン類の高分子結合体
EP2019122A4 (de) 2006-05-18 2009-07-01 Nippon Kayaku Kk Polymerkonjugat von podophyllotoxin
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
ES2584840T3 (es) * 2006-10-03 2016-09-29 Nippon Kayaku Kabushiki Kaisha Compuesto de un derivado de resorcinol con un polímero
EP2080779B1 (de) 2006-11-06 2016-05-18 Nippon Kayaku Kabushiki Kaisha Polymeres derivat eines nucleinsäuremetabolismus-antagonisten
JP5548365B2 (ja) 2006-11-08 2014-07-16 日本化薬株式会社 核酸系代謝拮抗剤の高分子誘導体
EP2206502B1 (de) 2007-09-28 2018-09-12 Nippon Kayaku Kabushiki Kaisha Polymer-konjugat eines steroids
US8920788B2 (en) 2008-03-18 2014-12-30 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of physiologically active substances
US9149540B2 (en) 2008-05-08 2015-10-06 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
WO2010131675A1 (ja) 2009-05-15 2010-11-18 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
US9018323B2 (en) 2010-11-17 2015-04-28 Nippon Kayaku Kabushiki Kaisha Polymer derivative of cytidine metabolic antagonist
JP5711378B2 (ja) 2011-09-11 2015-04-30 日本化薬株式会社 ブロック共重合体の製造方法
US10675354B2 (en) 2013-07-10 2020-06-09 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
US10098962B2 (en) * 2013-07-10 2018-10-16 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067503A (ja) * 1983-09-24 1985-04-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン類と多糖類との結合体
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
GB9213077D0 (en) 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
JP2610792B2 (ja) 1993-02-26 1997-05-14 株式会社ディ・ディ・エス研究所 多糖誘導体および薬物担体
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
WO1995011020A1 (en) 1993-10-20 1995-04-27 Enzon, Inc. 2'- and/or 7- substituted taxoids
US5760072A (en) * 1995-12-29 1998-06-02 Pharmachemie B.V. Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
EP1683520B1 (de) * 1996-03-12 2013-11-20 PG-TXL Company, L.P. Wasserlösliche Prodrugs
ATE310538T1 (de) * 1996-04-15 2005-12-15 Asahi Chemical Ind Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden

Also Published As

Publication number Publication date
WO1997038727A1 (fr) 1997-10-23
US6458347B1 (en) 2002-10-01
CA2251742A1 (en) 1997-10-23
EP0895784A1 (de) 1999-02-10
EP0895784A4 (de) 2003-03-19
DE69734709D1 (de) 2005-12-29
JP4420472B2 (ja) 2010-02-24
JP2009287036A (ja) 2009-12-10
EP0895784B1 (de) 2005-11-23
CA2251742C (en) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE310538T1 (de) Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden
BR0013949A (pt) Prodroga de taxano, composição farmacêutica, e, método de tratamento de um paciente mamìfero
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
NZ235285A (en) Bile acid - pharmaceutical conjugates, pharmaceutical compositions and bile acid-linker intermediates
EP1213285A3 (de) 4,5-Diphenyloxazolderivate und ihre Verendung als Blutplättchenaggregations-Inhibitoren
KR950014073A (ko) 이소퀴놀린
DE69122084T2 (de) 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
ATE178067T1 (de) Camptothecinderivate
KR870007947A (ko) 황-함유 그룹에 의해 치환된 5-아미노-4-하이드록시 발레릴 유도체 및 그의 제조 방법
WO1996030010A3 (fr) Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales
KR900001686A (ko) 4-옥소퀴놀린-3-카르복실산 유도체, 그의 제조방법 및 용도
AR004670A1 (es) Compuestos derivados de acido amino sustituido arilo y heteroarilo carboxilico; composicion farmaceutica que los contiene; metodo para aliviar eldolor; procedimiento para preparar dichos compuestos y compuestos utiles como material de partida
IE821846L (en) Carbamimidoyl-1-carbadethiapen-2-em-3 carboxylic acid
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
IE802661L (en) Isoquinoline acetic acids
AU5504694A (en) Substituted amic acid derivatives
ATE244735T1 (de) Niedrigviskose zusammensetzungen von epoxyfunktionellen polyesterharzen
EP0388956A3 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung
ATE196768T1 (de) Neue 6-hydroxy und 6-oxo-androstan verbindungen mit kardioaktivität und pharmazeutische präparate davon
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
NZ223287A (en) 4-thiazolidine carboxylic acid derivatives and pharmaceutical compositions
IL107315A0 (en) 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them
ES2065291B1 (es) "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
ES2103161A1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
ATE89719T1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties